Institut Paoli Calmettes Multiple Myeloma Database
NCT02869555 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2016-08-17
Summary
Database of Institut Paoli-Calmettes patients diagnosed with multiple myeloma
Conditions
Interventions
- OTHER
-
Data collection
Sponsors & Collaborators
-
Institut Paoli-Calmettes
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 95 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2030-01-31
- Completion
- 2030-12-31
Countries
- France
Study Locations
More Related Trials
-
A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.
NCT02164955 ·Status: COMPLETED
-
Multiple Myeloma Minimal Residual Disease
NCT02627261 ·Status: COMPLETED
-
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
NCT02921828 ·Status: COMPLETED
-
Immunophenotyping of Plasma Cells and Immune Effector Cells in Peripheral Whole Blood and Bone Marrow Samples From Multiple Myeloma (MM) Patients
NCT05428163 ·Status: COMPLETED
-
Stem Cell Translpantation in Multiple Myeloma
NCT05082675 ·Status: COMPLETED ·Phase: PHASE2
-
Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
NCT01382615 ·Status: TERMINATED
-
Immune Profiling in Multiple Myeloma
NCT04135079 ·Status: COMPLETED
-
Geriatric Assessments in Senior Adults With Multiple Myeloma
NCT01746030 ·Status: COMPLETED
-
A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Spain
NCT03602755 ·Status: COMPLETED
-
Familial Dysglobulinemia
NCT02853214 ·Status: COMPLETED ·Phase: NA
-
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
NCT03127761 ·Status: RECRUITING
-
Patient and Care Partner Experiences Living With Multiple Myeloma (PaCE-MM)
NCT05276622 ·Status: TERMINATED
-
Biomarkers in Multiple Myeloma
NCT05259553 ·Status: RECRUITING ·Phase: NA
-
Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma
NCT05355987 ·Status: COMPLETED ·Phase: NA
-
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
NCT05050097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years
NCT01671826 ·Status: UNKNOWN
-
Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma
NCT02800954 ·Status: COMPLETED ·Phase: NA
-
Vulnerability and Therapeutic Changes in Older Patients With Multiple Myeloma.
NCT02063113 ·Status: TERMINATED ·Phase: NA
-
Multiple Myeloma Turkish Prospective Patient Registry
NCT04143932 ·Status: UNKNOWN
-
Pomalidomide in Gene Expression Profiling (GEP)-Defined High-risk Multiple Myeloma
NCT01177735 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain
NCT02946333 ·Status: COMPLETED
-
Thrombosis in Patients With Multiple Myeloma in an University Medical Center
NCT05541978 ·Status: COMPLETED
-
Quality of Life the Danish Multiple Myeloma Patients
NCT02892383 ·Status: COMPLETED
-
Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients
NCT02918695 ·Status: COMPLETED
-
Lenalidomide Adherence in Older Adults
NCT03779555 ·Status: TERMINATED